PharVision Advisers »

Fortrea Hldgs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Fortrea Hldgs (FTRE) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Fortrea Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Fortrea Hldgs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fortrea Hldgs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $141k 17k 8.42
2024-12-31 $345k 19k 18.65

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Fortrea Hldgs

BlackRock
Vanguard Group
Goldman Sachs Group
Corvex Management
State Street Corporation
Sessa Capital IM
AQR Capital Management
FMR
Morgan Stanley
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Park West Asset Management
Geode Capital Management
Nuveen
Beck Mack & Oliver

View all funds holding Fortrea Hldgs